South Korean Trade In Pharma Tech
A new report from South Korea's Ministry of Health and Social Affairs says that from 1985 to August 1994, 31 technologies from 22 overseas countries were imported by the pharmaceutical sector.
The leading importer was Korea Green Cross, which imported 10 technologies, followed by Il Dong, Reyon and Dong Kook with two each. The greatest number of exports came from the USA, with 10, followed by Japan with seven, Russia with five and the UK with four, says a report on the study in Pharma Japan.
The report also notes that technologies for the development of new drugs were exported by five South Korean organizations during the period. These technologies, which the report notes have been used only in the initial screening stages of new drug development, were:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze